(R)-(1-(1-phenylethyl)-1H-imidazol-5-yl)(4-phenylpiperazin-1-yl)methanone

ID: ALA4760134

PubChem CID: 155669604

Max Phase: Preclinical

Molecular Formula: C22H24N4O

Molecular Weight: 360.46

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@H](c1ccccc1)n1cncc1C(=O)N1CCN(c2ccccc2)CC1

Standard InChI:  InChI=1S/C22H24N4O/c1-18(19-8-4-2-5-9-19)26-17-23-16-21(26)22(27)25-14-12-24(13-15-25)20-10-6-3-7-11-20/h2-11,16-18H,12-15H2,1H3/t18-/m1/s1

Standard InChI Key:  XYDJLLFNNKHPKK-GOSISDBHSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   11.0642  -13.2780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4403  -13.8215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6017  -14.6320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3865  -14.9001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0101  -14.3475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8454  -13.5389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7939  -14.6077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9583  -15.4171    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.3968  -16.0235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8066  -16.7435    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.6169  -16.5776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7067  -15.7554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4243  -15.3431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4131  -14.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4275  -14.5170    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.1349  -15.7561    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.1302  -16.5756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8366  -16.9886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5520  -16.5833    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.5564  -15.7604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8455  -15.3429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2585  -16.9983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2515  -17.8213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9597  -18.2370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6753  -17.8308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6782  -17.0046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9694  -16.5926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  9 10  2  0
  8  9  1  0
 10 11  1  0
 11 12  2  0
 12  8  1  0
 12 13  1  0
  7 14  1  1
 13 15  2  0
 13 16  1  0
 16 17  1  0
 16 21  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 19 22  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4760134

    ---

Associated Targets(Human)

GPBAR1 Tchem G-protein coupled bile acid receptor 1 (1723 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 360.46Molecular Weight (Monoisotopic): 360.1950AlogP: 3.45#Rotatable Bonds: 4
Polar Surface Area: 41.37Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.78CX LogP: 3.18CX LogD: 3.17
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.72Np Likeness Score: -1.30

References

1. Zhao S,Li X,Wang L,Peng W,Ye W,Li W,Wang YD,Chen WD.  (2021)  Design, synthesis and evaluation of 1-benzyl-1H-imidazole-5-carboxamide derivatives as potent TGR5 agonists.,  32  [PMID:33440321] [10.1016/j.bmc.2020.115972]

Source